- PICC Group reported year-to-date life premium income of 102.6 billion yuan as of November.
- The company accumulated 496.85 billion yuan in property and casualty insurance premium income for the same period.
- Investment analysts’ consensus shows 12 buy recommendations, 6 hold recommendations, and no sell recommendations for PICC Group.
“`
A look at People’s Insurance (PICC) Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 5 | |
Growth | 4 | |
Resilience | 3 | |
Momentum | 5 | |
OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
People’s Insurance Company (PICC) seems to have a promising long-term outlook based on the Smartkarma Smart Scores. With top scores in Value and Dividend, it indicates that the company is undervalued and provides strong dividend returns to investors. Additionally, a solid score in Momentum suggests that the company is performing well in terms of stock price movement. Growth, although slightly lower, still indicates positive potential for expansion. However, with a resilience score of 3, there may be some concerns about how well the company can withstand market disruptions.
The People’s Insurance Company (Group) of China Limited, a provider of property and casualty insurance products along with asset management services, seems to be well-positioned for future growth based on the Smartkarma Smart Scores. Investors may find comfort in the high scores for Value and Dividend, indicating strong financial fundamentals and consistent returns. While the Growth score highlights positive potential, the Resilience score suggests a need for caution in the face of market challenges. Overall, PICC presents a balanced outlook with opportunities for long-term investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars